Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Exanthema × Hydrocortisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 47 Leukemia 28 Prostatic Neoplasms 21 Burkitt Lymphoma 17 Leukemia, Biphenotypic, Acute 15 Lymphoma 13 Leukemia, Myeloid, Acute 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Large B-Cell, Diffuse 6 Recurrence 5 Lymphoma, Non-Hodgkin 5 Myelodysplastic Syndromes 4 Hodgkin Disease 4 Pituitary Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Lymphoma, T-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, B-Cell 3 Dendritic Cell Sarcoma, Interdigitating 3 Breast Neoplasms 3 Anemia, Refractory, with Excess of Blasts 3 Rhabdoid Tumor 2 Polycystic Ovary Syndrome 2 Obesity 2 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Myelomonocytic, Juvenile 2

Interventions

Gels 2 Fulvestrant 2 Doxycycline 2 Dapsone 2 ruxolitinib 1 dexpanthenol 1 ceterizine hydrochloride 1 capivasertib 1 benralizumab 1 Triamcinolone Acetonide 1 Tetracycline 1 Sirolimus 1 Provitamins 1 Prednisone 1 Panitumumab 1 Minocycline 1 Loperamide 1 Irinotecan 1 Interviews as Topic 1 IFL protocol 1 Hydrocortisone 1 HIV Testing 1 Fibroblast Growth Factor 7 1 Erlotinib Hydrochloride 1 Clindamycin 1 Cetuximab 1 Anti-Bacterial Agents 1 Alpelisib 1 Acitretin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00473083 2017-04-04

LUTRAERL

British Columbia Cancer Agency

Phase 2 Completed

150 enrolled 13 charts

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡